With the rapid development of the global pharmaceutical industry, capital strategies are playing an increasingly pivotal role in the growth of pharmaceutical enterprises. Beyond traditional equity financing, mergers and acquisitions, and licensing agreements, the Newco model has emerged as an innovative capital strategy, offering novel financing channels and commercial approaches for the sector.

This salon will focus on the innovative application of the Newco model in pharmaceutical capital operations, aiming to establish a platform for communication and collaboration. We cordially invite industry stakeholders, investors, and corporate representatives to explore how this model can optimize resource allocation and accelerate innovation and development within the pharmaceutical industry. Participants are encouraged to engage in in-depth discussions, identify partnership opportunities, and collectively propel the industry to new heights.